261 related articles for article (PubMed ID: 26001129)
1. C-reactive protein and risk of breast cancer: A systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Lu J; Sun X
Sci Rep; 2015 May; 5():10508. PubMed ID: 26001129
[TBL] [Abstract][Full Text] [Related]
2. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis.
Li J; Jiao X; Yuan Z; Qiu H; Guo R
Medicine (Baltimore); 2017 Aug; 96(34):e7822. PubMed ID: 28834887
[TBL] [Abstract][Full Text] [Related]
4. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
Wang X; Huang Y; Li L; Dai H; Song F; Chen K
Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer.
Mikkelsen MK; Lindblom NAF; Dyhl-Polk A; Juhl CB; Johansen JS; Nielsen D
Crit Rev Clin Lab Sci; 2022 Nov; 59(7):480-500. PubMed ID: 35403550
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
7. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
Villaseñor A; Ambs A; Ballard-Barbash R; Baumgartner KB; McTiernan A; Ulrich CM; Neuhouser ML
Breast Cancer Res Treat; 2011 Sep; 129(2):485-94. PubMed ID: 21455669
[TBL] [Abstract][Full Text] [Related]
8. Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M
Breast Cancer Res Treat; 2010 Dec; 124(3):785-91. PubMed ID: 20411322
[TBL] [Abstract][Full Text] [Related]
9. A predictive role of C-reactive protein in colorectal cancer risk: an updated meta-analysis from 780,985 participants and 11,289 cancer cases.
Han L; Guo Y; Ren D; Hui H; Li N; Xie X
Int J Colorectal Dis; 2023 May; 38(1):121. PubMed ID: 37160817
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein gene polymorphisms and myocardial infarction risk: a meta-analysis and meta-regression.
Zhu Y; Liu T; He H; Sun Y; Zhuo F
Genet Test Mol Biomarkers; 2013 Dec; 17(12):873-80. PubMed ID: 24010569
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris.
Jia RF; Li L; Li H; Cao XJ; Ruan Y; Meng S; Wang JY; Jin ZN
Am J Cardiol; 2020 Apr; 125(7):1039-1045. PubMed ID: 32014245
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches.
Mun H; Liu B; Pham THA; Wu Q
Osteoporos Int; 2021 Mar; 32(3):425-435. PubMed ID: 32935169
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis on the association between C-reactive protein levels and adverse limb events after revascularization in patients with peripheral arterial disease.
Di X; Han W; Liu CW; Ni L; Zhang R
J Vasc Surg; 2021 Jul; 74(1):317-326. PubMed ID: 33684473
[TBL] [Abstract][Full Text] [Related]
16. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
[TBL] [Abstract][Full Text] [Related]
17. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.
Wang J; Lee IM; Tworoger SS; Buring JE; Ridker PM; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1199-206. PubMed ID: 25994740
[TBL] [Abstract][Full Text] [Related]
18. Circulating C-Reactive Protein and Breast Cancer Risk-Systematic Literature Review and Meta-analysis of Prospective Cohort Studies.
Chan DS; Bandera EV; Greenwood DC; Norat T
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1439-49. PubMed ID: 26224798
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
[TBL] [Abstract][Full Text] [Related]
20. Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: A Systematic Review and Meta-Analysis.
Forat-Yazdi M; Jafari M; Kargar S; Abolbaghaei SM; Nasiri R; Farahnak S; Foroughi E; Neamatzadeh H
J Res Health Sci; 2017 Oct; 17(4):e00396. PubMed ID: 29233949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
